Analysis of p21(WAF1/CIP1) in primary bladder tumors Journal Article


Authors: Lacombe, L.; Orlow, I.; Silver, D.; Gerald, W. L.; Fair, W. R.; Reuter, V. E.; Cordon-Cardo, C.
Article Title: Analysis of p21(WAF1/CIP1) in primary bladder tumors
Abstract: The p21(WAF1/CIP1) gene is regulated by p53 and encodes a cyclin- dependent kinase (Cdk)-inhibitor involved in senescence and cell quiescence. The role of p21 as a negative regulator of cell proliferation suggests that it may function as a tumor suppressor gene. However, only a few mutations of the p21(WAF1/CIP1) gene have been reported to date. In order to assess potential p21(WAF1/CIP1) gene alterations in human bladder cancer, we have examined this gene and its encoded product in a well-characterized cohort of 27 primary bladder tumors. Mobility shifts by single-strand conformation polymorphism in the p21(WAF1/CIP1) gene were identified in 2 cases. Sequencing analyses revealed that one of these cases had point mutations in the 3' untranslated region, while the other case had a frame shift mutation at positions 322 (C to A) and a deletion of 8 nucleotides (323→331; CCG→ACG, codon 81 Arg→Thr) that produced a stop signal at codon 83 (Gly→Stop). This tumor had a p21-negative phenotype by immunohistochemistry, but did not lose any allele. We further characterized these cases by the study of TP53 mutations using single-strand conformation polymorphism (PCR- SSCP) and sequencing, as well as immunohistochemical assays. Seven mobility shifts were identified and seven cases showed p53 nuclear accumulation. The two cases displaying mutated p21(WAF1/CIP1) had wild-type TP53. It is concluded that p21(WAF1/CIP1) gene aberrations are infrequent in bladder carcinoma but may be occasionally identified in primary bladder tumors.
Keywords: adult; clinical article; human tissue; aged; aged, 80 and over; middle aged; gene mutation; gene sequence; genetics; mutation; polymerase chain reaction; metabolism; cell cycle; pathology; bladder cancer; bladder tumor; urinary bladder neoplasms; physiology; cancer genetics; oncogene; tumor suppressor gene; biosynthesis; dna; dna, neoplasm; urinary bladder; cyclin dependent kinase inhibitor 1a; cyclin-dependent kinase inhibitor p21; cycline; carcinoma, transitional cell; cyclins; transitional cell carcinoma; genes, tumor suppressor; cdkn1a protein, human; p21(waf1/cip1); single strand conformation polymorphism; humans; human; male; female; priority journal; article
Journal Title: Oncology Research
Volume: 8
Issue: 10-11
ISSN: 0965-0407
Publisher: Cognizant Communication Corporation  
Date Published: 1996-01-01
Start Page: 409
End Page: 414
Language: English
PUBMED: 9114433
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Citation Impact
MSK Authors
  1. William L Gerald
    375 Gerald
  2. Irene Orlow
    240 Orlow
  3. Victor Reuter
    1199 Reuter
  4. William R Fair
    342 Fair
  5. Louis Lacombe
    19 Lacombe